Corvus Pharmaceuticals, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 46.6M |
| FY2023 | 48.0M |
| FY2024 | 61.0M |
| FY2025 | 79.7M |
| FY2026 | 84.0M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 46.6M |
| FY2023 | 48.0M |
| FY2024 | 61.0M |
| FY2025 | 79.7M |
| FY2026 | 84.0M |